Schedule 13G ownership disclosure

Trevi Therapeutics Inc

Security class unavailable · CUSIP: 89532M101

Event date: 2024-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,391,577
Percent of class
1.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001622627-24-000043
Form type
SC 13G/A
Filer
Rosalind Advisors, Inc.
CIK
CIK 1622627
Filed
Jul 11, 2024
Reporting period
Jun 28, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub